This privacy notice discloses the privacy practices for ScipherMedicine.com and PrismRA.com. This privacy notice applies solely to information collected by this website. It will notify you of the following:
What personally identifiable information is collected from you through the website, how it is used and with whom it may be shared.
What choices are available to you regarding the use of your data.
The security procedures in place to protect the misuse of your information.
How you can correct any inaccuracies in the information.
Information Collection, Use, and Sharing
We are the sole owners of the information collected on this site. We only have access to collect information that you voluntarily give us via email or other direct contact from you. We will not sell or rent this information to anyone.
We will use your information to respond to you, regarding the reason you contacted us. We will not share your information with any third party outside of our organization.
Your Access to and Control Over Information
You may opt out of any future contacts from us at any time. You can do the following at any time by contacting us via the contact form on our website:
See what data we have about you, if any.
Change/correct any data we have about you.
Have us delete any data we have about you.
Express any concern you have about our use of your data.
We take precautions to protect your information. Do not include sensitive or personal information via our contact form.
When you contact us via email, social media, or the contact form, only authorized Scipher employees have access to the information.
Precision medicine for autoimmune diseases
Scipher MedicineTM, a molecular data company founded on the principles of Network Medicine, holds the fundamental belief that patients deserve answers to their treatment options using scientifically backed data.
With artificial intelligence and its proprietary molecular technology platform, Scipher Medicine develops diagnostic tests that analyze patients’ unique molecular signatures to accurately predict response to targeted therapeutics. By amassing the data from these tests, the company develops more effective therapies.